+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Suppositories Market - Global Forecast 2025-2030- Product Image
Suppositories Market - Global Forecast 2025-2030- Product Image
Sale

Suppositories Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6160599
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Suppositories Market grew from USD 1.54 billion in 2024 to USD 1.63 billion in 2025. It is expected to continue growing at a CAGR of 5.95%, reaching USD 2.18 billion by 2030.

Shaping the Future of the Suppository Market with Insightful Context

The suppository market has evolved from a niche pharmaceutical segment into a critical delivery mechanism that addresses diverse patient needs across therapeutic areas. By delivering active compounds through rectal, urethral, or vaginal routes, this modality ensures rapid onset, localized effects, and reduced systemic side effects. Recent technological innovations and shifting patient preferences have intensified interest in this format, positioning it as an integral component of broader treatment portfolios.

This executive summary outlines key market drivers, disruptive shifts, and segmentation insights that shape current dynamics. It highlights regulatory changes, trade policy adjustments, and detailed regional and competitive landscapes. Decision-makers will find actionable perspectives on how evolving patient demographics and distribution channels influence growth. By presenting a concise yet thorough overview, this section sets the stage for deeper analysis and strategic recommendations aimed at optimizing market penetration and long-term value creation.

Uncovering Transformative Shifts Reshaping Suppository Dynamics

Rapid advancements in formulation science have enabled novel excipient systems and controlled-release matrices, elevating suppositories from traditional gels to sophisticated drug delivery platforms. Concurrently, digitization of clinical trials and supply chains has accelerated time-to-market and fostered real-time quality monitoring. Regulatory agencies have responded with streamlined pathways for reformulations of approved compounds, encouraging manufacturers to revisit legacy products with fresh technological rigor.

Patient expectations have shifted as well, driven by heightened awareness of personalized medicine and the desire for discreet, convenient dosing options. Telehealth consultations increasingly recommend rectal or vaginal administration when oral dosing is contraindicated, underscoring the modality’s strategic value. As cross-sector partnerships proliferate, pharmaceutical firms are collaborating with excipient specialists and device engineers to unlock new therapeutic possibilities. These transformative forces converge to redefine the suppository landscape, setting the stage for sustained innovation and market expansion.

Assessing the Cumulative Impact of New US Tariffs on Suppository Trade

In 2025, the implementation of updated tariff schedules in the United States introduces significant cost pressures on imported active pharmaceutical ingredients and raw materials utilized in suppository production. Supply chains that once relied heavily on low-cost sourcing from key manufacturing hubs will face increased duties, prompting strategic realignment. Domestic producers may benefit from protective measures, yet they must balance higher input costs against competitive pricing.

The ripple effects extend to retail and hospital pharmacies, where procurement teams will reassess supplier portfolios to mitigate margin erosion. Manufacturers are already exploring near-shoring and dual-sourcing strategies to preserve supply continuity while containing duty impacts. As distributors recalibrate inventory management and negotiate revised contracts, the market will witness a shift toward vertically integrated models. This realignment underscores the need for agile trade policy response plans and underscores the importance of robust scenario planning to navigate the evolving tariff environment.

Illuminating Segmentation Insights Driving Market Differentiation

Therapeutic application remains a pivotal lens for understanding value creation in the suppository segment. Analgesic offerings continue to dominate due to high prevalence of pain management needs, while anti‐inflammatory variants gain traction for targeted local relief. Antihemorrhoidal formulations, segmented into non-steroidal and steroidal categories, address both acute flare-ups and chronic conditions, offering differentiated pharmacodynamic profiles. Laxative suppositories serve an essential role in bowel regimen protocols, particularly in hospital settings where rapid onset is critical.

Administration route influences both patient acceptance and clinical utility. Rectal suppositories hold the largest share due to familiarity and ease of use, whereas urethral and vaginal applications are witnessing steady growth as niche gynecological and urological treatments expand. Distribution channel dynamics shape access and convenience; hospital pharmacies, spanning government and private institutions, remain cornerstone outlets for acute care settings. Online pharmacies are disrupting traditional ordering pathways, catering to home-care patients who value discretion and doorstep delivery. Retail pharmacies-both chain and independent-provide front-line engagement with consumers, leveraging over-the-counter positioning to drive awareness.

Age group segmentation reveals nuanced demand patterns. Adult users represent the mainstream base, while geriatric populations require specialized formulations with gentler excipients. Pediatric applications, though smaller in volume, emphasize palatability and size considerations to ensure compliance in young patients. Together, these layers of segmentation illuminate growth pockets and guide product development priorities.

Exploring Regional Variations That Define Global Suppository Performance

Regional landscapes in the suppository market diverge based on healthcare infrastructure, reimbursement frameworks, and patient demographics. Across the Americas, strong hospital networks and rising telemedicine uptake facilitate broader access to suppository therapies, especially for chronic pain and gastrointestinal conditions. Price sensitivity in certain Latin American markets prompts manufacturers to optimize cost structures, while advanced economies in North America emphasize premium formulations with extended-release properties.

Within the Europe, Middle East & Africa region, regulatory harmonization efforts across the European Union coexist with market fragmentation in the Middle East and Africa. This creates a tapestry of opportunities for both established players and emerging local manufacturers. In Western Europe, streamlined approval processes for reformulations support rapid introduction of innovative excipient technologies. Meanwhile, growing mining of fragmented markets in North Africa and the Gulf Cooperation Council highlights the importance of targeted distribution partnerships.

Asia-Pacific exhibits diverse trajectories. Mature markets such as Japan and Australia drive demand for high-purity APIs and specialized delivery systems, whereas fast-growing economies in Southeast Asia and India prioritize affordability and scalability. Public-private partnerships in healthcare infrastructure expansions are poised to elevate refinery-to-retail capabilities, fostering stronger domestic production and reducing dependency on imports.

Analyzing Leading Players Steering Suppository Innovation

The competitive arena is defined by leading pharmaceutical houses that have invested heavily in R&D to differentiate their suppository portfolios. Some top contenders leverage in-house formulation capabilities to pioneer thermosensitive matrices that enhance patient comfort and absorption rates. Others forge alliances with contract development organizations to expedite pipeline expansions, enabling faster entry into niche therapeutic areas such as localized hemorrhoidal management.

Strategic acquisitions and licensing agreements are also reshaping the industry landscape. By integrating startups focused on novel excipients or advanced manufacturing techniques, incumbent players broaden their product breadth and fortify barriers to entry. At the same time, a wave of generics firms is intensifying price competition, prompting brand-owners to reinforce their offerings through value-added services such as digital adherence tools and educational outreach. This competitive interplay underscores the imperative to innovate not only in product formulation but also in end-to-end patient engagement strategies.

Strategic Recommendations to Elevate Suppository Market Leadership

To maintain a competitive edge, stakeholders should prioritize investment in next-generation excipient technologies that improve drug stability and patient comfort. Aligning formulation development with real-world evidence gathered through digital health platforms will accelerate regulatory approvals and inform more targeted clinical trials. Additionally, forging strategic partnerships with contract manufacturers in low-tariff jurisdictions can mitigate the impact of evolving trade policies.

On the distribution front, integrating omnichannel strategies that link hospital pharmacy supply chains with e-commerce platforms will drive greater market penetration, particularly in underserved demographics. Customized patient support programs designed for geriatric and pediatric cohorts can enhance adherence and foster brand loyalty. Finally, continuous monitoring of tariff developments and proactive engagement with policy stakeholders will equip organizations to anticipate shifts and secure supply chain resilience. By embracing these interconnected tactics, industry leaders can unlock sustainable growth and deliver superior patient outcomes.

Robust Research Methodology Ensuring Data Integrity and Insight

This study is underpinned by a rigorous methodology that integrates primary interviews with industry executives, formulary managers, and distribution experts. Detailed surveys captured end-user perspectives on formulation preferences and channel behaviors, while in-depth consultations with regulatory authorities provided clarity on evolving approval pathways.

Secondary research encompassed an exhaustive review of industry publications, patent filings, and trade associations to map competitive positioning and technology trends. Data triangulation was achieved by cross-referencing import-export statistics, corporate financial reports, and price monitoring databases. Qualitative insights were validated through expert workshops, ensuring that key findings reflect both quantitative rigor and practical relevance. This mixed-methods approach delivers a comprehensive and credible foundation for the analyses and recommendations presented throughout the report.

Concluding Perspectives on Suppository Market Trajectories

The suppository sector stands at a pivotal juncture, driven by formulation breakthroughs, evolving patient needs, and trade policy recalibrations. Segmentation analysis reveals clear pathways for focused innovation, while regional and competitive assessments underscore diverging market dynamics. As digital health continues to reshape how patients engage with therapies, manufacturers and distributors alike must adapt swiftly to maintain relevance and capture emerging opportunities.

Looking ahead, a balanced approach that integrates technological advancement with agile supply chain strategies will distinguish market leaders from followers. By harnessing the insights and recommendations detailed in this summary, decision-makers can chart informed pathways toward sustained growth and enhanced patient value. This comprehensive overview serves as a strategic compass for navigating the complexities of the global suppository market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Rectal Suppositories
    • Urethral Suppositories
    • Vaginal Suppositories
  • Material Type
    • Emulsifying Bases
    • Fatty Bases
    • Glycerinated Gelatin Base
    • Polyethylene Glycol Base
      • PEG 3350
      • PEG 4000
    • Water-Soluble Bases
  • Prescription Type
    • Over-the-Counter (OTC) Drugs
    • Prescription Drugs (Rx)
  • Therapeutic Application
    • Analgesic
      • Acetaminophen Analgesic
      • NSAID Analgesic
    • Anti Inflammatory
    • Antibacterial & Antifungal
    • Antiemetic
    • Antihemorrhoidal
      • Non Steroidal Formulation
      • Steroidal Formulation
    • Laxative
  • End User
    • Home Care
    • Hospitals & Clinics
  • Distribution Channel
    • Offline Pharmacy
    • Online Pharmacy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Novartis AG
  • SANOFI WINTHROP INDUSTRIE
  • Zydus Group
  • Church & Dwight Co., Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aspen Holdings
  • Haleon Group of Companies
  • Cipla Limited
  • Gulf Pharmaceutical Industries
  • Prestige Consumer Healthcare Inc.
  • Bliss GVS Pharma Ltd
  • Corden Pharma
  • Recipharm AB
  • Pfizer Inc.
  • LGM Pharma, LLC
  • Aenova Group
  • Bayer AG
  • Aliyan Pharmaceuticals LLP
  • Adragos Pharma GmbH

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Anatomy of Suppositories: Evolution, Significance, and Industry Dynamics
3.2. Decoding Consumer Demand and Competitive Forces in the Suppositories Market
3.3. Lifecycle and Intellectual Property Blueprint for Suppositories
3.4. Mapping Future Growth Trajectories and Innovation Trends in Suppositories
4. Market Overview
4.1. Introduction
4.1.1. Suppositories Defined: Economic Significance and Growth Levers
4.1.2. Regional Dynamics Shaping the Suppositories Landscape
4.1.3. Recent Innovations and Strategic Moves Driving Suppository Advancement
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of temperature stable lipid based suppositories for tropical markets
5.1.1. Redefining Suppository Stability for Tropical Climates
5.1.2. Disrupting Supply Chains and Competitive Dynamics
5.1.3. Navigating Future Pathways Amid Emerging Challenges
5.2. Expansion of suppository markets in emerging economies driven by rising healthcare access
5.2.1. Understanding the Surge in Suppository Demand Amid Healthcare Access Growth
5.2.2. Transformational Dynamics in Emerging Suppository Markets
5.2.3. Navigating Future Paths and Risks in Expanding Suppository Markets
5.3. Advancements in 3d printing enabling personalized suppository dosing and rapid prototyping
5.3.1. Personalized Suppository Manufacturing Redefined by 3D Printing
5.3.2. Disrupting the Suppository Market Through Rapid Prototyping and Custom Dosing
5.3.3. Navigating Future Paths and Risks for 3D-Printed Suppositories
5.4. Emerging preference for plant derived and natural excipient based suppository formulations
5.4.1. Nature's Revolution in Suppository Excipients
5.4.2. Redefining the Suppository Value Chain with Botanical Excipients
5.4.3. Navigating the Future of Natural Suppositories
5.5. Growing regulatory shifts streamlining approval of novel rectal drug delivery systems
5.5.1. Unpacking the Shift in Regulatory Approval for Rectal Drug Delivery
5.5.2. Transforming the Suppository Landscape Through Expedited Approval Pathways
5.5.3. Navigating Future Regulatory Pathways and Risks in Suppository Innovation
5.6. Rising demand for pediatric and geriatric suppositories with tailored dosing solutions
5.6.1. Understanding the Surge in Pediatric and Geriatric Tailored Suppositories
5.6.2. How Customized Dosing Is Reshaping the Suppository Market
5.6.3. Navigating Future Pathways Amid Evolving Pediatric and Geriatric Needs
5.7. Development of mucoadhesive polymer formulations enhancing controlled drug release profiles
5.7.1. Mucoadhesive Polymers: Foundations of Controlled Release in Suppositories
5.7.2. Reshaping the Suppository Market through Adhesive Polymer Innovation
5.7.3. Navigating Future Pathways for Mucoadhesive Suppository Advancements
5.8. Integration of digital health monitoring to optimize patient adherence and outcomes
5.8.1. Harnessing Digital Health Monitoring for Suppository Adherence
5.8.2. Transforming the Suppository Market Through Connected Care
5.8.3. Navigating the Future of Digital Suppository Solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Capital, Compliance, and Brand Loyalty Keep New Players at Bay
6.1.2. Substitutes Looming in Evolving Treatment Choices
6.1.3. Supplier Leverage in Raw Materials and APIs
6.1.4. Buyer Influence over Pricing and Product Preferences
6.1.5. Competitive Intensity Drives Innovation and Pricing Pressure
6.2. PESTLE Analysis
6.2.1. Shifting Drug Approval Landscapes Influence Suppository Market
6.2.2. Economic Pressures and Healthcare Spending Patterns
6.2.3. Evolving Patient Preferences and Stigma Dynamics
6.2.4. Innovations in Formulation and Delivery Systems
6.2.5. Stringent Pharmaceutical Regulations and Compliance Costs
6.2.6. Sustainability Imperatives and Supply Chain Resilience
7. Cumulative Impact of United States Tariffs 2025
7.1. Shifting Duties: The 2023-2025 Tariffs Reshaping American Trade
7.2. From Steel to Solar: The Political Logic Behind Recent Tariff Policies
7.3. Rising Prices Abroad and at Home: How Tariffs Are Fanning Inflation
7.4. Tit-for-Tat Duties: Trade Wars Across the Americas, EMEA, and Asia-Pacific
7.5. Ripple Effects: How Tariffs Are Reshaping Partner Economies and Politics
7.6. Supply Chain Overhaul: Long-Term Industry Shifts Driven by Tariffs
7.7. Charting a Path Forward: Strategies to Soften Tariff-Induced Strains
8. Suppositories Market, by Product Type
8.1. Introduction
8.2. Rectal Suppositories
8.3. Urethral Suppositories
8.4. Vaginal Suppositories
9. Suppositories Market, by Material Type
9.1. Introduction
9.2. Emulsifying Bases
9.3. Fatty Bases
9.4. Glycerinated Gelatin Base
9.5. Polyethylene Glycol Base
9.5.1. PEG 3350
9.5.2. PEG 4000
9.6. Water-Soluble Bases
10. Suppositories Market, by Prescription Type
10.1. Introduction
10.2. Over-the-Counter (OTC) Drugs
10.3. Prescription Drugs (Rx)
11. Suppositories Market, by Therapeutic Application
11.1. Introduction
11.2. Analgesic
11.2.1. Acetaminophen Analgesic
11.2.2. NSAID Analgesic
11.3. Anti Inflammatory
11.4. Antibacterial & Antifungal
11.5. Antiemetic
11.6. Antihemorrhoidal
11.6.1. Non Steroidal Formulation
11.6.2. Steroidal Formulation
11.7. Laxative
12. Suppositories Market, by End User
12.1. Introduction
12.2. Home Care
12.3. Hospitals & Clinics
13. Suppositories Market, by Distribution Channel
13.1. Introduction
13.2. Offline Pharmacy
13.3. Online Pharmacy
14. Americas Suppositories Market
14.1. Introduction
14.2. Mexico
14.3. Canada
14.4. Brazil
14.5. United States
14.6. Argentina
15. Europe, Middle East & Africa Suppositories Market
15.1. Introduction
15.2. Netherlands
15.3. Nigeria
15.4. Italy
15.5. France
15.6. Denmark
15.7. Finland
15.8. Egypt
15.9. United Arab Emirates
15.10. South Africa
15.11. Switzerland
15.12. Spain
15.13. Qatar
15.14. Poland
15.15. Germany
15.16. Saudi Arabia
15.17. Norway
15.18. Russia
15.19. Turkey
15.20. Israel
15.21. Sweden
15.22. United Kingdom
16. Asia-Pacific Suppositories Market
16.1. Introduction
16.2. Thailand
16.3. Singapore
16.4. South Korea
16.5. Australia
16.6. Malaysia
16.7. Vietnam
16.8. Japan
16.9. Philippines
16.10. China
16.11. India
16.12. Taiwan
16.13. Indonesia
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.1.1. Novartis AG’s Journey and Strategic Footprint in Suppositories
17.3.1.2. Flagship Suppository Offerings Driving Patient Outcomes
17.3.1.3. Navigating Risks and Reinforcing Market Significance
17.3.2. SANOFI WINTHROP INDUSTRIE
17.3.2.1. Flagship Suppository Solutions Driving Patient Outcomes
17.3.2.2. Mitigating Threats and Fortifying Significance in Suppositories
17.3.3. Zydus Group
17.3.3.1. Zydus Group’s Evolution and Market Leadership in Suppositories
17.3.3.2. Flagship Suppository Offerings and Their Alignment with Patient Needs
17.3.3.3. Navigating Risks and Strategic Pathways to Strengthen Suppository Portfolio
17.3.4. Church & Dwight Co., Inc.
17.3.4.1. Evaluating Core Suppository Products Against Consumer Pain Points
17.3.4.2. Addressing Risks and Strengthening Future Suppository Competitiveness
17.3.5. Bausch Health Companies Inc.
17.3.5.1. From Legacy to Leadership in Rectal Drug Delivery
17.3.5.2. Precision Formulations Delivering Patient-Centric Relief
17.3.5.3. Proactive Strategies to Secure Future Growth
17.3.6. Teva Pharmaceutical Industries Ltd.
17.3.6.1. Teva’s Evolution and Market Leadership in Suppositories
17.3.6.2. Flagship Suppository Offerings and Patient-Centric Relevance
17.3.6.3. Navigating Risks and Fortifying Suppository Market Position
17.3.7. Sun Pharmaceutical Industries Ltd.
17.3.7.1. Assessing Flagship Suppository Formulations and Market Reception
17.3.7.2. Navigating Risks and Charting Strategic Pathways for Suppository Growth
17.3.7.3. Future Outlook and Strategic Imperatives
17.3.8. Aspen Holdings
17.3.8.1. Aspen Holdings’ Rise and Strategic Presence in the Suppositories Market
17.3.8.2. Flagship Suppository Offerings and Their Alignment with Patient Needs
17.3.8.3. Key Risks and Strategic Pathways for Aspen’s Suppository Business
17.3.9. Haleon Group of Companies
17.3.9.1. Flagship Suppository Offerings Driving Consumer Preference
17.3.9.2. Navigating Threats and Fortifying Future Growth in Suppositories
17.3.10. Cipla Limited
17.3.10.1. Cipla’s Evolution and Footprint in Rectal Drug Delivery
17.3.10.2. Evaluation of Cipla’s Flagship Suppository Portfolio
17.3.10.3. Navigating Risks and Fortifying Cipla’s Suppository Ambitions
17.3.11. Gulf Pharmaceutical Industries
17.3.11.1. Evaluating Flagship Suppository Formulations Against Patient Needs
17.3.11.2. Mitigating Risks and Strategizing Future Suppository Growth
17.3.12. Prestige Consumer Healthcare Inc.
17.3.12.1. From Foundation to Frontline: Prestige’s Evolution in Suppositories
17.3.12.2. Flagship Suppositories Shaping Consumer Relief Experiences
17.3.12.3. Strategic Shielding and Expansion for Suppository Leadership
17.3.13. Bliss GVS Pharma Ltd
17.3.13.1. In-Depth Review of Bliss GVS’s Flagship Suppository Offerings
17.3.13.2. Navigating Risks and Strategic Pathways for Suppository Growth
17.3.14. Corden Pharma
17.3.14.1. Corden Pharma’s Evolution and Strategic Footprint in Suppository Manufacturing
17.3.14.2. Examining Corden Pharma’s Core Suppository Solutions and Market Alignment
17.3.14.3. Navigating Risks and Charting Strategic Initiatives for Suppository Market Leadership
17.3.15. Recipharm AB
17.3.15.1. Recipharm AB’s Evolution and Global Suppository Footprint
17.3.15.2. In-Depth Review of Recipharm’s Suppository Portfolio and Market Alignment
17.3.15.3. Mitigating Risks and Driving Growth in Recipharm’s Suppository Business
17.3.16. Pfizer Inc.
17.3.16.1. Pfizer’s Evolution and Influence in the Suppository Arena
17.3.16.2. Deep Dive into Pfizer’s Suppository Solutions and Services
17.3.16.3. Navigating Risks and Charting Growth Strategies for Pfizer’s Suppository Business
17.3.17. LGM Pharma, LLC
17.3.17.1. LGM Pharma's Evolution and Market Reach in the Suppository Sector
17.3.17.2. In-Depth Evaluation of LGM Pharma’s Flagship Suppository Offerings
17.3.17.3. Anticipating Threats and Strengthening LGM Pharma’s Suppository Leadership
17.3.18. Aenova Group
17.3.18.1. From Roots to Leadership in Suppository Manufacturing
17.3.18.2. Flagship Suppository Solutions Exceeding Patient Expectations
17.3.18.3. Navigating Risks and Fortifying Future Suppository Success
17.3.19. Bayer AG
17.3.19.1. Bayer’s strategic evolution and market footprint in the suppository segment
17.3.19.2. Analyzing Bayer’s flagship suppositories: formulations, performance, and patient impact
17.3.19.3. Mitigating threats and elevating Bayer’s suppository portfolio for future dominance
17.3.20. Aliyan Pharmaceuticals LLP
17.3.20.1. Aliyan’s Evolution From Generic Manufacturer to Suppository Innovator
17.3.20.2. Showcasing Flagship Formulations and Consumer-Centric Differentiation
17.3.20.3. Addressing Regulatory, Supply Chain, and Competitive Risks
17.3.21. Adragos Pharma GmbH
17.3.21.1. Adragos Pharma’s Evolution and Strategic Footprint in Suppository Drug Delivery
17.3.21.2. Deep Dive into Adragos’s Flagship Suppository Offerings and Market Performance
17.3.21.3. Navigating Risks and Charting Strategic Enhancements for Suppository Growth
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SUPPOSITORIES MARKET MULTI-CURRENCY
FIGURE 2. SUPPOSITORIES MARKET MULTI-LANGUAGE
FIGURE 3. SUPPOSITORIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SUPPOSITORIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SUPPOSITORIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SUPPOSITORIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SUPPOSITORIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SUPPOSITORIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SUPPOSITORIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUPPOSITORIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SUPPOSITORIES MARKET SIZE, BY RECTAL SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUPPOSITORIES MARKET SIZE, BY URETHRAL SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUPPOSITORIES MARKET SIZE, BY VAGINAL SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUPPOSITORIES MARKET SIZE, BY EMULSIFYING BASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUPPOSITORIES MARKET SIZE, BY FATTY BASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUPPOSITORIES MARKET SIZE, BY GLYCERINATED GELATIN BASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 3350, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 4000, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SUPPOSITORIES MARKET SIZE, BY WATER-SOLUBLE BASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SUPPOSITORIES MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION DRUGS (RX), BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SUPPOSITORIES MARKET SIZE, BY ACETAMINOPHEN ANALGESIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SUPPOSITORIES MARKET SIZE, BY NSAID ANALGESIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTI INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIBACTERIAL & ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIEMETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SUPPOSITORIES MARKET SIZE, BY NON STEROIDAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SUPPOSITORIES MARKET SIZE, BY STEROIDAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SUPPOSITORIES MARKET SIZE, BY LAXATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SUPPOSITORIES MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SUPPOSITORIES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 57. MEXICO SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 63. CANADA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 66. CANADA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 67. CANADA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 119. NIGERIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 120. NIGERIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. NIGERIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 122. NIGERIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 123. NIGERIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. NIGERIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ITALY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 128. ITALY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 131. ITALY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 132. ITALY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. FRANCE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. FRANCE SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 140. FRANCE SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. DENMARK SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. DENMARK SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 145. DENMARK SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 146. DENMARK SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 147. DENMARK SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. DENMARK SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 149. DENMARK SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 150. DENMARK SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. FINLAND SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. FINLAND SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. FINLAND SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 155. FINLAND SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 156. FINLAND SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. FINLAND SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 158. FINLAND SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 159. FINLAND SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. FINLAND SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. EGYPT SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 167. EGYPT SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 168. EGYPT SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. EGYPT SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 191. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SPAIN SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SPAIN SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 201. SPAIN SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 203. SPAIN SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 204. SPAIN SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. QATAR SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. QATAR SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. QATAR SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 209. QATAR SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 210. QATAR SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. QATAR SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 212. QATAR SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 213. QATAR SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. QATAR SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. POLAND SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 217. POLAND SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 218. POLAND SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 221. POLAND SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 222. POLAND SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. GERMANY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. GERMANY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 226. GERMANY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 228. GERMANY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. GERMANY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 230. GERMANY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 231. GERMANY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. GERMANY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 248. NORWAY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 249. NORWAY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. TURKEY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 266. TURKEY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 267. TURKEY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. TURKEY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 294. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 306. THAILAND SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. THAILAND SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. THAILAND SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 309. THAILAND SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 310. THAILAND SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. THAILAND SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 312. THAILAND SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 313. THAILAND SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. THAILAND SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. SINGAPORE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. SINGAPORE SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 317. SINGAPORE SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 318. SINGAPORE SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 319. SINGAPORE SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. SINGAPORE SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 321. SINGAPORE SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 322. SINGAPORE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. SINGAPORE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 326. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 327. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 328. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 330. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 331. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. SOUTH KOREA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 347. MALAYSIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2030 (USD MILLION)
TABLE 349. MALAYSIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. MALAYSIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Suppositories market report include:
  • Novartis AG
  • SANOFI WINTHROP INDUSTRIE
  • Zydus Group
  • Church & Dwight Co., Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aspen Holdings
  • Haleon Group of Companies
  • Cipla Limited
  • Gulf Pharmaceutical Industries
  • Prestige Consumer Healthcare Inc.
  • Bliss GVS Pharma Ltd
  • Corden Pharma
  • Recipharm AB
  • Pfizer Inc.
  • LGM Pharma, LLC
  • Aenova Group
  • Bayer AG
  • Aliyan Pharmaceuticals LLP
  • Adragos Pharma GmbH

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.18 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Reports

Suppository Production Line Market - Global Forecast to 2030 - Product Image

Suppository Production Line Market - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Suppositories Market by Type (Urethral, Rectal, Vaginal), Base (Oleaginous, Aqueous, Emulsifying), Prescription (OTC, Prescribed), Application (Analgesic, Laxatives, Anti-fungal, Nasal Decongestants), Patient (Adult & Pediatrics) - Global Forecast to 2030 - Product Image

Suppositories Market by Type (Urethral, Rectal, Vaginal), Base (Oleaginous, Aqueous, Emulsifying), Prescription (OTC, Prescribed), Application (Analgesic, Laxatives, Anti-fungal, Nasal Decongestants), Patient (Adult & Pediatrics) - Global Forecast to 2030

  • Report
  • 271 Pages
  • Global
From
Suppository Packaging Market - Global Forecast 2025-2030 - Product Image

Suppository Packaging Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Pharmaceutical Suppositories Market Report 2025 - Product Image

Pharmaceutical Suppositories Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Trichomoniasis Market Report and Forecast 2025-2034 - Product Image

Trichomoniasis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.